Spectranetics (SPNC) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 4:03 PM EDTExpands Stellarex Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC) today reported financial results for the three months ended March 31, 2015. Highlights of the quarter, all compared with the three months ended March 31, 2014 include:
Revenue of $57.4 million, up 45% (47% constant currency1) Vascular Intervention revenue of $36.5 million grew 82% (84% constant currency) U.S. peripheral atherectomy revenue grew 16% AngioSculpt® revenue of $14.0 million achieved Lead Management revenue of $16.4 million increased 14% (16% constant... More